Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
219 Leser
Artikel bewerten:
(1)

NextPlat Corp.: NextPlat Reports Record Consolidated Q1 2024 Revenues of $17.5 Million Compared to $2.9 Million in Q1 2023 (508% Increase) as Quarterly Margins Improve to 27.5%

Finanznachrichten News

Proposed Merger Agreement with Progressive Care Inc., Launch of its E-Commerce Development Program with Alibaba's Tmall Global and Acquisition of Outfitters Expected to Drive Continued Top-Line Growth

COCONUT GROVE, Fla., May 15, 2024 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced record financial results for the first fiscal quarter ended March 31, 2024 which includes the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care").

"First quarter results continued to demonstrate the fundamental strength of NextPlat's focus on the large healthcare services and global e-commerce technology markets and further demonstrates our team execution against its global growth plans," said Charles M. Fernandez, Executive Chairman and CEO of NextPlat Corp. "Throughout the remainder of 2024, we are committed to maximizing and unlocking the unrealized value in our business, further building upon the strong financial and technical foundation we have created and our growing list of global partners and customers. We intend to achieve our near-term goals by capitalizing on our ability to significantly improve the efficiency of our business through our proposed merger with Progressive Care and the opportunity to add multiple new high value healthcare and e-commerce revenue streams to our platform."

First Quarter 2024 Financial Highlights:

  • Consolidated revenues for the quarter ended March 31, 2024, were approximately $17.5 million, an increase of over 508% versus revenue of approximately $2.9 million for the quarter ended March 31, 2024. Results for the first quarter of 2024 reflect e-commerce revenue of approximately $2.9 million and approximately $14.6 million in revenue contributed from the Company's healthcare operations (specifically, Progressive Care whose results are consolidated as of July 1, 2023).
  • Gross margins for the quarter ended March 31, 2024, increased significantly to 27.5%, up from 21.6% reported for the quarter ended March 31, 2023, primarily attributable to the healthcare operations because of the Progressive Care consolidation. Gross profit margin attributable to our healthcare operations was approximately 27% (for the consolidation period). Our e-commerce profit margins improved to 28% from 22% reported in the quarter ended March 2024, driven largely by continued increases in the sales of higher margin, recurring airtime revenue.
  • Operating expenses for the quarter ended March 31, 2024, were approximately $6.7 million compared to approximately $1.9 million in the year-ago period, an increase of approximately $4.8 million. Selling, general and administrative ("SG&A") increased by approximately $1.2 million and was mainly attributable to the increase in stock-based compensation of approximately $0.4 million, other operating expenses as it relates to the e-Commerce operations of approximately $0.4 million, and approximately $0.4 million as it relates to operating expenses of the healthcare operations as a result of the Progressive Care acquisition on July 1, 2023. Salaries, wages and payroll taxes increased by $2.0 million and was mainly attributable to the healthcare operations as a result of the Progressive Care acquisition as of July 1, 2023. Professional fees, primarily legal and consulting, increased by approximately $0.7 million, and depreciation and amortization expenses increased by approximately $0.7 million.
  • Net loss for the quarter ended March 31, 2024, was approximately $1.5 million, or ($0.08) per diluted share compared to a net loss of approximately $1.2 million, or ($0.08) diluted earnings per share reported for the quarter ended March 31, 2023.
  • The Company ended the first quarter of 2024 with approximately $23.5 million in cash.

Organizational Highlights and Recent Business Developments:

  • In the first quarter, the Company's technology e-commerce business saw positive sequential quarterly improvement including positive increases in global transaction volumes for satellite phones and tracking devices despite the expected seasonality in the business and continued tight inventory and product availability. Demand for high margin, recurring airtime contracts remains at monthly record levels, driving quarterly margins on airtime sales to near record levels. On April 1, 2024, NextPlat completed the acquisition of Outfitter Satellite Inc. ("Outfitter"), significantly expanding its North American technology e-commerce business. The Company is actively supporting Outfitter's new and existing customers while it quickly works to expand and modernize its e-commerce presence including integrating its operations onto its global ERP system expected to be completed by the end of the second quarter.
  • The Company's healthcare business, Progressive Care, saw a significant 28% increase in revenue in the first quarter of 2024, driven by 16% growth in pharmacy prescriptions and a 110% increase in its 340B contract services business versus the first quarter of 2023.
  • On April 12, 2024, NextPlat announced a proposed business combination with Progressive Care Inc. in an all-stock transaction which is expected to provide revenue synergies and significant annual operating cost reductions. Effective as of July 1, 2023, Progressive Care became a consolidated subsidiary of NextPlat for accounting purposes as a result of the controlling interest in Progressive Care obtained by the Company in concert with the Company's Executive Chairman and CEO, Charles M. Fernandez, and its Director, Rodney Barreto.
  • The Company's exclusive OPKO Healthcare ("OPKO")-branded storefront in China on Alibaba's Tmall Global platform, was launched on March 1, 2024. Since its initial launch, the Company has continued to enhance the OPKO storefront with additional product listings. At launch, the OPKO-branded storefront initially listed health and wellness products including an assortment of nutraceuticals for bone, joint and eye health as well as supplements for nutrition and immunity defense. The OPKO online storefront will see significant expansion with the addition of a wide array of veterinary and animal health products starting in the second quarter of 2024 subject to receipt of the final government approvals. Product marketing programs supported by Alibaba's local trading partner is expected to commence later in the second quarter.
  • During the quarter, the Company continued to make progress as it prepares for the formal introduction of its Florida Sunshine line of branded vitamins and supplements. This new commerce development program is expected to be launched on Alibaba's Tmall Global platform in China in the third quarter of 2024, further expanding its e-commerce and healthcare offerings.

David Phipps, President of NextPlat and CEO of Global Operations, added, "Healthcare, technology and e-commerce continue to be among the largest and most important sectors of the global economy today and is why NextPlat is committed to investing into near-term opportunities and launching multiple new offerings this year. By leveraging our e-commerce development program with Alibaba and its Tmall Global platform in China, expanding our healthcare footprint for services and products, and adding complementary connectivity offerings to our growing product portfolio, we will continue to demonstrate the strength and value of our diversified business model."

The financial information included in this press release should be read in conjunction with the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, which will be filed with the Securities and Exchange Commission later today.

For more information regarding the financial results of Progressive Care Inc. for the quarter ended March 31, 2024, investors should refer to its Quarterly Report on Form 10-Q which will be filed with the Securities and Exchange Commission later today.

About NextPlat Corp
RXMD).

Important Information About the Merger and Where to Find It

www.sec.gov, or by directing a request to: NextPlat Corp, 3250 Mary St., Suite 410, Coconut grove, FL 33133, Attention: Chief Financial Officer, Telephone: (305) 560-5355.

Participants in the Solicitation

www.sec.gov, or by directing a request to NextPlat Corp, 3250 Mary St., Suite 410, Coconut grove, FL 33133, Attention: Chief Financial Officer, Telephone: (305) 560-5355. Additional information regarding the interests of such participants will be contained in the proxy statement for the Merger when available.

Progressive Care and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of NextPlat in connection with the Merger. A list of the names of such directors and executive officers and information regarding their interests in the Merger will be included in the proxy statement for the Merger when available.

No Offer or Solicitation

This Current Report on Form 8-K shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Merger. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.

Forward-Looking Statements

Media and Investor Contact for NextPlat Corp:
[email protected]

NEXTPLAT CORP AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In thousands, except per shares data)




Three Months Ended



Three Months Ended




March 31, 2024



March 31, 2023




(Unaudited)



(Unaudited)











Sales of products, net


$

14,120



$

2,876


Revenues from services



3,373




-


Revenue, net



17,493




2,876











Cost of products



12,620




2,255


Cost of services



63




-


Cost of revenue



12,683




2,255











Gross profit



4,810




621











Operating expenses:









Selling, general and administrative



2,005




788


Salaries, wages and payroll taxes



2,624




588


Impairment loss



132




-


Professional fees



985




321


Depreciation and amortization



906




162


Total operating expenses



6,652




1,859











Loss before other (income) expense



(1,842)




(1,238)











Other (income) expense:









Interest expense



21




5


Interest earned



(215)




(10)


Other income



-




(50)


Foreign currency exchange rate variance



26




(28)


Total income expense



(168)




(83)











Loss before income taxes and equity in net loss of affiliate



(1,674)




(1,155)











Income taxes



(27)




-


Loss before equity in net loss of affiliate



(1,701)




(1,155)











Equity in net loss of affiliate



-




(32)


Net loss



(1,701)




(1,187)











Net loss attributable to noncontrolling interest



220




-


Net loss attributable to NextPlat Corp


$

(1,481)



$

(1,187)











Comprehensive income (loss):









Net loss


$

(1,701)



$

(1,187)


Foreign currency loss



(27)




(23)


Comprehensive loss


$

(1,728)



$

(1,210)











NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS


$

(1,481)



$

(1,187)


Weighted number of common shares outstanding - basic and diluted



18,725




14,415











Loss per share - basic and diluted


$

(0.08)



$

(0.08)


NEXTPLAT CORP AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except shares and par data)




March 31, 2024



December 31, 2023




(Unaudited)



(Audited)


ASSETS









Current Assets









Cash


$

23,526



$

26,307


Accounts receivable, net



12,928




8,923


Receivables - other, net



2,068




1,846


Inventory, net



5,610




5,135


Unbilled revenue



185




189


VAT receivable



357




342


Prepaid expenses



404




640


Notes receivable due from related party



260




256


Total Current Assets



45,338




43,638











Property and equipment, net



3,846




3,989











Goodwill



731




731


Intangible assets, net



13,725




14,423


Operating right of use assets, net



1,303




1,566


Finance right-of-use assets, net



18




22


Deposits



39




39


Prepaid expenses, net of current portion



61




61


Total Other Assets



15,877




16,842


Total Assets


$

65,061



$

64,469











LIABILITIES AND EQUITY


















Current Liabilities









Accounts payable and accrued expenses


$

14,893



$

13,176


Contract liabilities



140




42


Notes payable



233




312


Due to related party



42




18


Operating lease liabilities



532




532


Finance lease liabilities



20




18


Income taxes payable



90




139


Total Current Liabilities



15,950




14,237











Long Term Liabilities:









Notes payable, net of current portion



1,165




1,211


Operating lease liabilities, net of current portion



853




929


Finance lease liabilities, net of current portion



-




5


Total Liabilities



17,98




16,382











Commitments and Contingencies



-




-











Equity









Preferred stock ($0.0001 par value; 3,333,333 shares authorized)



-




-


Common stock ($0.0001 par value; 50,000,000 shares authorized, 18,724,596 and 18,724,596 shares issued and
outstanding as of March 31, 2024 and December 31, 2023, respectively)



2




2


Additional paid-in capital



67,717




67,170


Accumulated deficit



(36,406)




(34,925)


Accumulated other comprehensive loss



(90)




(63)


Equity attributable to NextPlat Corp stockholders



31,223




32,184


Equity attributable to noncontrolling interests



15,870




15,903


Total Equity



47,093




48,087











Total Liabilities and Equity


$

65,061



$

64,469


SOURCE NextPlat Corp.

© 2024 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.